O2‐05‐02: AMYLOID BIOMARKERS FOR AD: CURRENT STATUS AND NOVEL FINDINGS

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Alzheimer's & Dementia

• Publication date

  2014-07-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1016/J.JALZ.2014.04.181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Artificial neural networks fighting real neural decline: a systematic review of AI in Alzheimer’s research

  2026cites this paper
• Convergence analysis of the acyclic hypercubic HMM Baum-Welch algorithm

  2025cites this paper
• Anterior Insula Drives Progressive Structural Brain Network Atrophy in the Behavioural Variant of Frontotemporal Dementia

  2025cites this paper
• Cortical thickness changes precede high levels of amyloid by at least seven years

  2025cites this paper
• Humanized APOE mouse brain volume increases over age irrespective of sex and APOE genotype: Implications for translational validity to the human

  2025cites this paper
• Joint Progression Modeling (JPM): A Probabilistic Framework for Mixed-Pathology Progression

  2025cites this paper
• Staging of Alzheimer's disease progression in Down syndrome using mixed clinical and plasma biomarker measures with machine learning

  2025cites this paper
• Independent validation and outlier analysis of EuroPOND Alzheimer’s disease staging model using ADNI and real-world clinical data

  2025influential citation
• Bayesian Event-Based Model for Disease Subtype and Stage Inference

  2025cites this paper
• Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum

  2025cites this paper
• An Integrated Data-Driven Model for Clinical Phenotyping of Tuberculosis Disease Severity

  2025cites this paper
• A dynamic time series inference learning framework for individualized prediction of mild cognitive impairment progression

  2025cites this paper
• Emerging Trends in Early Dementia Diagnosis: An Analysis on Advanced Machine Learning Approaches

  2025cites this paper
• Temporal dynamic of cognitive decline in type 2 diabetes mellitus patients: a multimodal biomarker analysis using event-based modal and principal component analysis

  2025cites this paper
• A Stage-Aware Mixture of Experts Framework for Neurodegenerative Disease Progression Modelling

  2025cites this paper
• Quantifying surprise in clinical care: Detecting highly informative events in electronic health records with foundation models

  2025cites this paper
• Unrevealing the sequence of dysphagia progression in ALS: an event-based, FEES-driven staging approach.

  2025cites this paper
• Comprehensive Anatomical Staging Predicts Clinical Progression in Mild Cognitive Impairment: A Data-Driven Approach

  2025cites this paper
• ReduXis: A Comprehensive Framework for Robust Event-Based Modeling and Profiling of High-Dimensional Biomedical Data

  2025cites this paper
• Data-driven, cross-sectional image-based subtyping and staging of brain volumetric changes in Parkinson's disease.

  2025cites this paper
• Sequence of decline on the NIH-toolbox cognitive battery in a predominantly Latino sample with autosomal dominant Alzheimer's disease

  2025cites this paper
• Striatal dopamine transporter uptake predicts neuronal hypometabolism and visuospatial function in Parkinson’s disease

  2025cites this paper
• Distinct spatiotemporal patterns of white matter hyperintensity progression

  2025cites this paper
• Beyond the usual suspects: multi-factorial computational models in the search for neurodegenerative disease mechanisms

  2024influential citation
• Unscrambling disease progression at scale: fast inference of event permutations with optimal transport

  2024influential citation
• Data-driven sequence of cognitive decline in people with Parkinson’s disease

  2024cites this paper
• Interpretable deep clustering survival machines for Alzheimer's disease subtype discovery

  2024cites this paper
• Understanding the Temporal Dynamics of Accelerated Brain Aging and Resilient Brain Aging: Insights from Discriminative Event-Based Analysis of UK Biobank Data

  2024cites this paper
• Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson's disease.

  2024cites this paper
• Progression of hippocampal subfield atrophy and asymmetry in Alzheimer's disease

  2024influential citation
• Disease progression modeling with temporal realignment: An emerging approach to deepen knowledge on chronic diseases.

  2024cites this paper
• Dimensional Neuroimaging Endophenotypes: Neurobiological Representations of Disease Heterogeneity Through Machine Learning.

  2024cites this paper
• Robust and interpretable AI-guided marker for early dementia prediction in real-world clinical settings

  2024cites this paper
• Dimensional Neuroimaging Endophenotypes: Neurobiological Representations of Disease Heterogeneity Through Machine Learning

  2024influential citation
• Associations between cardiometabolic multimorbidity and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study

  2024cites this paper
• Data-driven modelling of neurodegenerative disease progression: thinking outside the black box

  2024influential citation
• Disease staging of Alzheimer’s disease using a CSF-based biomarker model

  2024influential citation
• Analysis of fractal-fractional Alzheimer's disease mathematical model in sense of Caputo derivative

  2024cites this paper
• A Novel Score to Predict Individual Risk for Future Alzheimer’s Disease: A Longitudinal Study of the ADNI Cohort

  2024cites this paper
• Understanding the complex interplay between tau, amyloid and the network in the spatiotemporal progression of Alzheimer's Disease

  2024cites this paper
• s-SuStaIn: Scaling subtype and stage inference via simultaneous clustering of subjects and biomarkers

  2024cites this paper
• Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis

  2024cites this paper
• Parsimonious EBM: generalising the event-based model of disease progression for simultaneous events

  2024influential citation
• Distinct spatiotemporal patterns of cortical thinning in Alzheimer’s disease-type cognitive impairment and subcortical vascular cognitive impairment

  2024cites this paper
• Probabilistic clustering using shared latent variable model for assessing Alzheimer's disease biomarkers.

  2024cites this paper
• Clustering disease trajectories in contrastive feature space for biomarker discovery in age-related macular degeneration

  2023cites this paper
• Neurodegenerative disease of the brain: a survey of interdisciplinary approaches

  2023cites this paper
• Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease

  2023cites this paper
• Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer’s disease

  2023cites this paper
• Frontotemporal lobar degeneration

  2023cites this paper
• The temporal event-based model: Learning event timelines in progressive diseases

  2023cites this paper
• One-year prediction of cognitive decline following cognitive-stimulation from real-world data.

  2023cites this paper
• Heterogeneity in Preclinical Alzheimer’s Disease Trial Cohort Identified by Image-based Data-Driven Disease Progression Modelling

  2023cites this paper
• Current advances in pulmonary functional imaging.

  2023cites this paper
• X chromosome-wide association study of quantitative biomarkers from the Alzheimer’s Disease Neuroimaging Initiative study

  2023cites this paper
• sPDGFRβ and neuroinflammation are associated with AD biomarkers and differ by race: The ASCEND Study

  2023cites this paper
• A Multivariate Nonlinear Mixed Effects Model for A Multivariate Nonlinear Mixed Effects Model for Longitudinal Image Analysis: Application to Amyloid Longitudinal Image Analysis: Application to Amyloid Imaging Imaging

  2023cites this paper
• Disease2Vec: Encoding Alzheimer’s progression via disease embedding tree

  2023cites this paper
• Artificial Intelligence for Dementia Research Methods Optimization

  2023cites this paper
• Impact of sex and APOE-ε4 genotype on patterns of regional brain atrophy in Alzheimer's disease and healthy aging

  2023cites this paper
• A review of neuroimaging-based data-driven approach for Alzheimer’s disease heterogeneity analysis

  2023influential citation
• Current Challenges in the Diagnosis of Progressive Neurocognitive Disorders: A Critical Review of the Literature and Recommendations for Primary and Secondary Care

  2023cites this paper
• Neurophysiological trajectories in Alzheimer’s disease progression

  2023cites this paper
• Presence but not the timing of onset of REM sleep behavior disorder distinguishes evolution patterns in Parkinson's disease.

  2023cites this paper
• A multidimensional ODE-based model of Alzheimer’s disease progression

  2023cites this paper
• Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real‐world population‐based cohort

  2023cites this paper
• A discriminative event‐based model for subtype diagnosis of sporadic Creutzfeldt‐Jakob disease using brain MRI

  2023cites this paper
• Transferability of Alzheimer's disease progression subtypes to an independent population cohort

  2023cites this paper
• Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [18F]Florzolotau PET imaging and subtype/stage inference algorithm

  2023cites this paper
• Grid cell disruption in a mouse model of early Alzheimer’s disease reflects reduced integration of self-motion cues and increased influence of environmental geometry

  2022cites this paper
• Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn)

  2022cites this paper
• Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approach

  2022cites this paper
• S-EBM: Generalising event-based modelling of disease 1 progression for simultaneous events 2

  2022influential citation
• Spatial-Temporal Patterns of β-Amyloid Accumulation

  2022cites this paper
• Editorial: Multi-Modal Imaging in Neurological Conditions: Translational Applications

  2022cites this paper
• Toward a Multimodal Computer-Aided Diagnostic Tool for Alzheimer’s Disease Conversion

  2022cites this paper
• Subtyping brain diseases from imaging data

  2022cites this paper
• Categorical predictive and disease progression modeling in the early stage of Alzheimer's disease.

  2022cites this paper
• Artificial intelligence and MRI: the source of a new epilepsy taxonomy

  2022cites this paper
• Measurements, Algorithms, and Presentations of Reality: Framing Interactions with AI-Enabled Decision Support

  2022cites this paper
• Gray matter hypoperfusion is a late pathological event in the course of Alzheimer’s disease

  2022cites this paper
• Data-Driven Disease Progression Modelling

  2022influential citation
• Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes

  2022cites this paper
• Disease Progression Score Estimation From Multimodal Imaging and MicroRNA Data Using Supervised Variational Autoencoders

  2022influential citation
• A Mathematical Investigation of Sex Differences in Alzheimer’s Disease

  2022cites this paper
• Spatial-Temporal Patterns of Amyloid- β Accumulation A Subtype and Stage Inference Model Analysis

  2022cites this paper
• Simulating the progression of brain structural alterations in Parkinson’s disease

  2022cites this paper
• Event-based modeling of T1-weighted MRI is related to pathology in frontotemporal lobar degeneration due to tau and TDP

  2022cites this paper
• Computer-aided diagnosis and prediction in brain disorders

  2022cites this paper
• Riemannian Metric Learning for Progression Modeling of Longitudinal Datasets

  2022cites this paper
• Computational Psychiatry and Computational Neurology: Seeking for Mechanistic Modeling in Cognitive Impairment and Dementia

  2022cites this paper
• A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation

  2022cites this paper
• Microbiome and Metabolome Insights into the Role of the Gastrointestinal–Brain Axis in Parkinson’s and Alzheimer’s Disease: Unveiling Potential Therapeutic Targets

  2022cites this paper
• A data-driven model of brain volume changes in progressive supranuclear palsy

  2022cites this paper
• Event‐based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross‐sectional data

  2022cites this paper
• Disease2Vec: Representing Alzheimer's Progression via Disease Embedding Tree

  2021cites this paper
• Inter-Cohort Validation of SuStaIn Model for Alzheimer’s Disease

  2021cites this paper
• Staging and stratifying cognitive dysfunction in multiple sclerosis

  2021cites this paper
• Integrating molecular, histopathological, neuroimaging and clinical neuroscience data with NeuroPM-box

  2021cites this paper
• Investigating hypotheses of neurodegeneration by learning dynamical systems of protein propagation in the brain

  2021cites this paper